Background: Ornithine decarboxylase (ODC) plays a pivotal role in the synthesis of polyamines, a group of chemical compounds that are essential for cell growth. Recent reports have shown that ODC overexpression may be involved in malignant transformation of immortalized NIH 3T3 cells. We have demonstrated that ODC-overproducing mouse breast cancer cells are more invasive in vitro than control cells. However, little information is available concerning the relationship between ODC overexpression, tumor invasion, and metastasis and the signal transduction pathways involved in ODCinduced transformation and invasion. Purpose: Our purpose was twofold: 1) to determine whether ODC overexpression is directly involved in tumor cell invasion and 2) to determine whether ODC overexpression induces mitogenactivated protein (MAP) kinase activities that are associated with cell growth and transformation. Methods: We transfected C3H clone 8 mouse 10T1/2 fibroblasts with an expression vector that carries a complementary DNA encoding rat ODC. Neomycin-resistant cells that overproduced ODC (4-6.5 times the control levels) were isolated. The transformed phenotype of these cells was determined by assessing colony formation and anchorageindependent growth in soft agar. The invasiveness of the cells was studied by
The process of tumor metastasis consists of many complex steps, one of the most important being invasion through the basement membrane of blood vessels and lymphatics (1) . To invade the basement membrane, tumor cells must attach to it and degrade it. Matrix metalloproteinases (MMPs) are thought to play a pivotal role in degrading basement membranes because the activities of MMPs (especially MMP-2 and MMP-9) are related to the invasive and metastatic potential (2) .
Mitogen-activated protein (MAP) kinase is a key component of the signal transduction pathways triggered by numerous extracellular signals, including mitogens, growth factors, and oncogenic p21 ras [reviewed in (3) ]. Constitutive MAP kinase activation is associated with the transformed phenotype of human renal cell carcinomas (4) , and the immediate upstream activator of MAP kinase could cause cell transformation (5,6).
Ornithine decarboxylase (ODC) is a key regulatory enzyme in the biosynthesis of polyamines, a group of chemical compounds that are essential for cell growth. ODC plays a pivotal role in neoplastic transformation and in tumor growth (7); overexpression of ODC leads to cell transformation (8) (9) (10) . Little information is available concerning the relationship between ODC overexpression, tumor invasion, and metastasis and the signal transduction pathways involved in ODCinduced transformation and invasion. We previously reported that DL-alphadifluoromethylornithine (DFMO) significantly decreased the growth and the pulmonary metastasis of B16 melanoma cells in vivo (11) . Because DFMO inhibits B16 melanoma cell growth, whether or not ODC is directly involved in tumor invasion and metastasis needs to be determined. More recently, we found that ODC-overproducing mouse breast cancer cells showed a greater invasiveness in vitro than control breast cancer cells (12) .
The present study was done to ascertain whether ODC is directly involved in tumor cell invasion and to determine whether ODC overexpression induces MAP kinase activities. 6 ) were transfected with 10 g of the pcDL-SR␣/ODC cDNA construct and 500 ng of RSV Neo (17) (provided by Dr. Y. Yamada, National Institutes of Health, Bethesda, MD) or 10 g of empty pcDL-SR␣ and 500 ng of RSV Neo (control) by electroporation using Gene Pulser (Bio-Rad Laboratories, Tokyo), according to the manufacturer's instruction. Transfected cells were selected for resistance to 600 g/mL G418 (Boehringer Mannheim, Tokyo), an analogue of the antibiotic neomycin, after 2 weeks, isolated with cloning cylinders, and grown in DMEM containing G418. Four permanent ODC-overproducing cell lines (ODC-1, ODC-2, ODC-3, and ODC-4) and three control transfectants (Neo-1, Neo-2, and Neo-3) were established. Successful transfection was confirmed by Southern blot analysis using digoxigenin-labeled rat ODC cDNA as a probe (data not shown).
ODC enzyme assay. ODC activity was determined in triplicate by use of L- [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] C]ornithine hydrochloride (Amersham Life Science, Tokyo) as a substrate, as described previously (18) . ODC activity was expressed as nanomoles CO 2 /hour per milligram protein. The enzyme activity was determined in cells that were in log-phase growth. The cells were harvested for assay 60 hours after the last change of growth medium. The protein concentration was determined by the method of Bradford (19) , using a kit from Bio-Rad Laboratories and following the manufacturer's instruction.
Anchorage-independent growth assay. Cells (10 3 ) were suspended in a 0.4% agar (Wako Pure Chemicals, Ltd.) solution containing DMEM plus 10% FCS and overlaid onto a 0.53% agar solution containing DMEM plus 10% FCS in 35-mm dishes. The colonies were counted after 14 days of culture. Two independent experiments in triplicate were performed.
Zymogram analysis. A gelatin-substrate zymogram analysis and quantitation of MMP-2 activities were done, as described previously (20), using 45 L serum-free conditioned medium. Briefly, after cells were washed twice with serum-free DMEM, 2 × 10 5 cells were incubated with 300 L serum-free DMEM. After 24 hours, serum-free conditioned medium was collected. The cells were counted using a hemocytometer, and the numbers were not significantly different among 10T1/2, Neo-1, Neo-2, Neo-3, ODC-1, ODC-2, ODC-3, and ODC-4 cells. The MMP-2 activity was quantitated by scanning gels densitometrically by use of Macintosh Adobe Photoshop 2.5J and a histogram analysis program (Adobe Systems Japan, Tokyo).
MAP kinase assay. Cells were lysed in a buffer containing 20 mM Tris-HCl (pH 7.5), 10 mM EGTA, 60 mM ␤-glycerophosphate, 10 mM MgCl 2 , 1% Triton X-100, 2 mM dithiothreitol, 1 mM vanadate, 1 mM PMSF, 10 g/mL leupeptin, and 1% aprotinin, after which they were centrifuged at 15 000g for 25 minutes at 4°C. The supernatant (80 g) was used for the MAP kinase assay. The activity of MAP kinase was measured as described previously (21) . Briefly, the supernatant was subjected to sodium dodecyl sulfate-polyacrylamide (10%) gel electrophoresis in a gel containing 0.5 mg/mL MBP. After electrophoresis, proteins in the gel were denatured with 6 M guanidine-HCl, renatured with 0.04% Triton X-100 in 50 mM Tris-HCl (pH 8), and subjected to kinase assay (in-gel kinase assay). Gels were incubated in 50 mM HEPES (pH 8), 0.1 mM EGTA, 10 mM MgCl 2 , and 25 Ci [␥-32 P]adenosine triphosphate for 1 hour at 25°C. After the gels had been dried, they were exposed to x-ray film or to an imaging plate of Bio Imaging Analyzer Fuji-BAS 2000 (Fuji Film Co., Tokyo) for quantitation of kinase activities. In some experiments, MAP kinases were detected by immunoprecipitating the cell lysate (80 g) with 5 g of anti-MAP kinase monoclonal antibody (Zymed Laboratories, Inc., South San Francisco, CA) preabsorbed to protein A-Sepharose. Immune complexes were washed three times with cell lysis buffer and subjected to gel electrophoresis and in-gel kinase assay. Controls were anti-mouse immunoglobulin G antibody (Cosmo Bio, Tokyo), anti-mouse laminin antibody (Bio Makor, Rehovot, Israel), and anti-focal adhesion kinase monoclonal antibody (Upstate Biotechnology Inc., Lake Placid, NY).
Invasion assay. The invasion assay was done by use of Matrigel-coated filters in Boyden chambers, as we described previously (20) . To study the effects of DFMO, we pretreated cells with 0.5 mM or 2 mM DFMO in DMEM containing 10% FCS for 48 hours. After checking the viability by trypan blue dye exclusion (viability, >85%), we washed the cells twice with serum-free DMEM containing 0.1% bovine serum albumin and then carried out the invasion assay in triplicate. Cells penetrating the Matrigel were stained with Diff Quick (International Reagents Corp., Kobe, Japan), and the cells in 10 fields were counted under the microscope (×200-×400). This assay was done twice.
Statistical analyses. Analyses were performed by Student's t test using the SigmaPlot Program (Jandel Corporation, San Rafael, CA). P values <.05 were considered statistically significant in the two-sided tests.
Results

Transfection of ODC cDNA
To directly assess the effects of ODC overexpression on cell transformation and invasion, we inserted rat ODC cDNA into pcDL-SR␣ and transfected mouse 10T1/2 fibroblasts with these constructs and with mock plasmids and a selectable marker (RSV Neo). We chose 10T1/2 mouse fibroblasts instead of NIH 3T3 cells as recipient cells for transfection because our preliminary study showed that 10T1/2 fibroblasts were less invasive (one sixth) than NIH 3T3 cells, as determined by the invasion assay using Boyden chambers in vitro. Neomycin (G418)-resistant transfectants were selected after 2 weeks. There were 43 G418-resistant colonies in ODC cDNA transfectants and 39 in empty vector transfectants. All ODC cDNA transfectants exhibited loss of contact inhibition and formed foci at high densities. Representative colonies were isolated from both transfectants and designated ODC-1, ODC-2, ODC-3, and ODC-4 (10T1/2 cells transfected with ODC cDNA and RSV Neo) and Neo-1, Neo-2, and Neo-3 (10T1/2 cells transfected with the empty vector and RSV Neo).
The level of ODC activity present in ODC transfectants and mock transfectants was determined in cells in log-phase growth ( Table 1 ). The ODC transfectants consistently exhibited higher levels of ODC activity (ranging from 4-fold to 6.5-fold) than those detected in mock transfectants ( Table 1) .
Characterization of ODC cDNA-Overexpressed Cells
The influence of ODC gene overexpression on 10T1/2 cells was examined by monitoring acquisition of the transformation phenotype. Growth properties of the ODC cDNA transfectants are shown in Table 1 . All ODC-overproducing transfectants lost the potential to be inhibited by cell-to-cell contact. Fig. 1 shows a typical example of a multilayered colony formed by the overgrowth of ODCoverproducing transfectant.
We next studied the transfectants for anchorage-independent growth in culture. ODC-overproducing transfectants formed colonies in soft agar ( Table 1 ). The degree of colony-forming ability was related to the ODC activity. In contrast, control transfectants showed no anchorageindependent growth. We also checked anchorage-dependent growth (growth curves not shown). ODC-overproducing transfectants exhibited doubling times longer than those of control transfectants and 10T1/2 cells (Table 1) .
Invasive Phenotype Shown by ODC-Overproducing Transfectants
Because our previous study (11) showed that DFMO significantly decreased pulmonary metastasis of B16 melanoma cells in vivo and indicated that ODC may be involved in cancer cell invasion or metastasis, we next asked whether ODC-overproducing transfectants would become invasive. To test this hypothesis, we studied the invasiveness of the cells through a Matrigel-coated filter. ODC-1, ODC-2, ODC-3, and ODC-4 showed 2.2-fold, 2.1-fold, 2.7-fold, and 1.9-fold more invasiveness, respectively, compared with that of control transfectants (Neo-3) (Table 1) . Thus, ODC expression is associated with cell invasiveness.
The effects of DFMO on the invasiveness of ODC-3 cells were then examined. Treatment with 0.5 mM and 2 mM DFMO suppressed ODC-3 cell invasion by 22% and 58%, respectively. The effects of DFMO on the invasiveness of 10T1/2 cells and Neo-3 cells were also examined. Treatment with 2 mM DFMO suppressed 10T1/2 cell invasion and Neo-3 cell invasion by 11% and 19%, respectively. Therefore, ODC overexpression induced not only cell transformation but also cell invasiveness.
Secretion of MMP-2 by ODC-Overproducing Transfectants
We next investigated whether ODC transfectants secreted more MMP-2 than control transfectants did, because MMP-2 is considered to play a pivotal role in cancer cell invasion. As shown in Fig. 2 , A, ODC-1, ODC-2, ODC-3, and ODC-4 secreted 2.3-fold ± 0.1-fold (mean ± standard deviation), 2.3-fold ± 0.1-fold, 2.6-fold ± 0.2-fold, and 2.3-fold ± 0.1-fold more MMP-2, respectively, compared with findings in the control transfectant (Neo-3).
We also tested whether DFMO treatment could suppress MMP-2 activity of ODC-3. As shown in Fig. 2 , B, 0.5 mM and 2 mM DFMO suppressed MMP-2 activity in a dose-dependent manner.
Expression of Increased MAP Kinase Activity by ODC-Overproducing Transfectants
Inasmuch as two studies (5, 6) showed that constitutive, active MAP kinase kinase expression is associated with transformation, we next asked whether the transforming activity and the invasive activity induced by ODC overexpression were associated with the MAP kinase signal transduction pathway. To test this hypothesis, MAP kinase activity was measured by in-gel kinase assay by use of MBP as a substrate. As Fig. 3, A, shows, ODC-1, ODC-2, ODC-3, and ODC-4 showed 2.2-fold ± 0.1-fold (mean ± standard deviation), 2.8-fold ± 0.3-fold, 3.5-fold ± 0.2-fold, and 2.0-fold ± 0.1-fold enhanced MAP kinase (42 kd and 44 kd) activities, respectively, compared with observations in the control transfectant (Neo-3).
Immunoprecipitates with specific anti-MAP kinase antibody were also analyzed by in-gel kinase assay (Fig. 3, B) , and the 42-kd and 44-kd bands were confirmed to be MAP kinases. Activated forms of 42- *Neo-1, Neo-2, and Neo-3 were transfected with empty vector (pcDL-SR␣) and RSV Neo DNA. ODC-1, ODC-2, ODC-3, and ODC-4 were representative ODC-overexpressed transfectants.
†1 × 10 3 cells were plated in 0.4% agar with a 0.53% agar underlayer. The soft-agar results represent one experiment of two similar experiments performed.
‡ODC activities in cells were measured as described in the ''Materials and Methods'' section. ODC activities in ODC-1, ODC-2, ODC-3, and ODC-4 are significantly elevated compared with those in Neo-1, Neo-2, and Neo-3 (P<.05).
§2 × 10 5 cells were used for the invasion assay. The penetrated cells in 10 fields were counted under the microscope. Two independent experiments in triplicate were performed, and the mean number of cells is shown. The invasiveness of ODC-1, ODC-2, ODC-3, and ODC-4 was significantly higher than that of Neo-3 (P<.05).
Not determined. kd and 44-kd MAP kinases were not observed. The degree of enhanced MAP kinase activity (42 kd and 44 kd) in ODCoverproducing transfectants was associated with the magnitude of ODC activities, of colony-forming ability in soft agar, and of cell invasiveness (Table 1) .
We also tested whether DFMO could suppress MAP kinase activity of ODC-3 cells. As shown in Fig. 3 , C, 0.5 mM and 2 mM DFMO suppressed MAP kinase activity in a dose-dependent manner. These results suggest that enhanced MAP kinase (42 kd and 44 kd) activities in ODC-overproducing transfectants, as related to ODC overexpression, may be responsible for neoplastic transformation and cell invasion induced by ODC overexpression.
Discussion
Deregulated ODC expression and subsequent polyamine accumulation are intimately associated with a malignant state (7) . Studies have shown that ODC/ polyamines may be involved in malignant transformation of immortalized NIH 3T3 cells (8) (9) (10) and mouse keratinocytes (22) . However, little is known about the causal relationship between ODC expression and cell invasiveness. We have reported that ODC-overproducing mouse breast cancer cells showed a greater invasiveness in vitro than control breast cancer cells (12) . In the present study, we noted causal effects of ODC overexpression on cell invasion through Matrigel-coated filters. The invasion process is thought to be a key step in tumor metastasis. MMP-2 is considered to play a pivotal role in invasion processes (1, 2) . Indeed, ODCoverproducing cells in our study secreted more MMP-2 compared with findings in control transfectants. This result agrees with our previous finding that more MMP-2 was secreted by ODC-overproducing mouse breast cancer cells than by control breast cancer cells (12) .
The mechanisms by which overexpression of ODC leads 10T1/2 cells to malignant transformation and to the invasive phenotype are unknown. Auvinen et al. (23) reported that ODC-overexpressed NIH 3T3 cells showed an increased tyrosine phosphorylation of the p130 substrate of pp60 v-src , identical to the v-Crkassociating protein pp130 c a s , and treatment with tyrosine kinase inhibitors reversed the phenotype of ODCtransformed cells to normal (23) . In the present study, ODC-overproducing transfectants showed enhanced MAP kinase (42 kd and 44 kd) activities, events that are related to the magnitude of colonyforming ability and of cell invasiveness. The observations in ODC-overproducing transfectants are not nonspecific consequences due to increased growth rates. Rather, they are causal effects of ODC overexpression because ODC-overproducing transfectants in this study showed decreased growth rates. A decreased growth rate in ODC-overexpressing cells has been observed in several epidermal cell lines (22) and in mouse mammary carcinoma cells (12) . MAP kinase is a key component of the signal transduction pathways triggered by numerous extracellular signals, including oncogenic p21 ras (3). Constitutive MAP kinase activation is associated with the transformed phenotype of human renal cell carcinoma (4), and the MAP kinase kinase could cause cell transformation (5, 6) . To our knowledge, our data are the first demonstration of a connection between polyamine/ODC and MAP kinase signaling pathways and indicate that the MAP kinase pathway may be involved in ODC-induced cell transformation and invasion. We have also shown that ODC-overproducing transfectants became invasive concomitantly with secreting more MMP-2 compared with control transfectants and 10T1/2 cells. Although the mechanism of the enhancement of MMP-2 by ODC overexpression remains obscure, it seems likely that the enhancement of MMP-2 secretion was the consequence of MAP kinase enhancement by ODC overexpression. The results are not inconsistent with those of previous studies showing that activated ras oncogene transformed NIH 3T3 cells, induced invasion and MMP secretion (24, 25) , and activated MAP kinase (26) .
In summary, our results indicate that ODC overexpression is directly involved in acquisition of the transformed and invasive phenotype by mouse 10T1/2 fibroblasts. Transformation and invasion induced by ODC overexpression may be mediated through the MAP kinase signal transduction pathway.
